Lactobacillus CD2 Lozenges
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Lactobacillus CD2 Lozenges, covering 2013-02-20 to 2016-11-09. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-Dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Myeloablative Hematopoietic Stem Cell Transplantation [Phase 3]